BBIO ▼ -0.9% - BridgeBio Pharma, Inc. $BBIO - BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) BridgeBio Pharma fell 0.9% today following its announcement of inducement grants issued under Nasdaq rules. The company granted stock options and restricted stock units to newly hired employees as retention incentives, a routine disclosure that typically has minimal direct impact on share price, though the modest decline may reflect general market sentiment or sector headwinds rather than a reaction to the grant announcement itself. 18-SEP-2026 04:01 PM ET